Siemens Healthineers (ETR:SHL) received a €32.30 ($37.56) target price from investment analysts at JPMorgan Chase & Co. in a note issued to investors on Thursday, September 26th, Borsen Zeitung reports. The brokerage presently has a “sell” rating on the stock. JPMorgan Chase & Co.‘s price target would indicate a potential downside of 7.45% from the stock’s current price.
Several other equities research analysts also recently issued reports on SHL. Nord/LB set a €36.00 ($41.86) price objective on Siemens Healthineers and gave the stock a “neutral” rating in a research note on Monday, July 29th. Berenberg Bank set a €42.00 ($48.84) price objective on Siemens Healthineers and gave the stock a “buy” rating in a research note on Friday, July 12th. Independent Research set a €38.00 ($44.19) target price on Siemens Healthineers and gave the stock a “neutral” rating in a research report on Friday, August 16th. Deutsche Bank set a €35.00 ($40.70) target price on Siemens Healthineers and gave the stock a “neutral” rating in a research report on Friday, August 9th. Finally, DZ Bank reaffirmed a “buy” rating on shares of Siemens Healthineers in a research report on Monday, July 29th. One investment analyst has rated the stock with a sell rating, thirteen have assigned a hold rating and three have given a buy rating to the company’s stock. The company has a consensus rating of “Hold” and a consensus price target of €37.93 ($44.10).
Shares of ETR SHL traded up €0.37 ($0.43) during mid-day trading on Thursday, hitting €34.90 ($40.58). 603,665 shares of the company traded hands. The business has a 50 day moving average of €35.70 and a two-hundred day moving average of €36.49. The stock has a market capitalization of $34.90 billion and a price-to-earnings ratio of 24.42. The company has a quick ratio of 0.87, a current ratio of 1.30 and a debt-to-equity ratio of 55.12. Siemens Healthineers has a 1 year low of €31.90 ($37.09) and a 1 year high of €39.21 ($45.59).
Siemens Healthineers Company Profile
Siemens Healthineers AG develops, manufactures, and distributes imaging, advanced therapies, and diagnostic products and services to healthcare providers worldwide. It operates in three operating segments: Imaging, Advanced Therapies, and Diagnostics. The Imaging segment provides diagnostic imaging and ultrasound systems and solutions.
Recommended Story: What is an Initial Public Offering (IPO)?
Receive News & Ratings for Siemens Healthineers Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Siemens Healthineers and related companies with MarketBeat.com's FREE daily email newsletter.